B3GAT1 and prostate cancer: A decrease in maturity status (as determined by CD57%) was not anticipated to augment cytotoxic protein expression, as men with prostate cancer report CD56bright NK cells have substantially lower perforin MFI and CD57 expression compared to CD56dim (21).